ReviewThe Journal of veterinary medical science2026
Progress and prospects in HIV/AIDS pathogenicity research using rhesus macaque models: from SHIV model development to neutralizing antibody induction.
Review in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review systematically summarizes the development and applications of Simian-Human Immunodeficiency Virus (SHIV) models in rhesus macaques conducted by our research group from 2001 to 2023. Over this two-decade span, we have made significant contributions to HIV/AIDS research through the development and characterization of various SHIV models. Beginning with the isolation and characterization of molecular clones with different pathogenicities from SHIV-89.6P, we progressed to investigating the mechanisms of small intestinal CD4+ T cell depletion in SHIV infection. Subsequently, we developed R5-tropic SHIV models that better mimic natural HIV infection and conducted in-depth studies on neutralizing antibody induction and neutralization resistance. This review examines these research achievements chronologically, discusses their significance in understanding HIV/AIDS pathogenesis, and presents future research prospects in this field. Our findings have contributed substantially to elucidating the molecular mechanisms of HIV pathogenicity and establishing platforms for vaccine and therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.